Epaminurad 9 mg

DRUG2 trials

Sponsors

JW Pharmaceutical

Conditions

GoutHealthy Volunteers

Phase 1

PK,PD and DDI of Epaminurad and C2406 in Healthy Volunteers

CompletedNCT06665425

JW PharmaceuticalHealthy Volunteers

Start: 2025-03-24End: 2025-09-04Updated: 2026-04-20

Phase 3

A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients

CompletedNCT05815901

JW PharmaceuticalGout

Start: 2023-03-21End: 2026-04-23Updated: 2026-05-04